Removal of Impella® 2.5 while maintaining vascular access: A solution to a vascular quandary
Removal of Impella® 2.5 while maintaining vascular access: A solution to a vascular quandary
复制标题
去除 Impella® 2.5，同时保持血管通路：血管困境的解决方案
DOI：
--
复制
发表时间：
2014
影响因子：
2.3
通讯作者：
J. Messenger
中科院分区：
文献类型：
--
作者：
Michael S. Kim;Stacey D. Clegg;J. Messenger
急性心肌梗死背景下的心源性休克（CS）与高住院死亡率相关。学会指南为ST段抬高心肌梗死后CS患者使用血流动力学支持器械提供了Ib类建议。血液动力学支持器械的更换通常因在抗凝治疗中取出器械后无法维持经皮血管通路而变得复杂。本报告强调了一种可能的解决方案，以解决在移除Impella® 2.5机械支撑装置后维持血管通路的困境，从而使难治性CS患者安全过渡到TandemHeart系统。© 2013威利期刊公司.
Cardiogenic shock (CS) in the setting of acute myocardial infarction is associated with high in‐hospital mortality rates. Society guidelines provide a Class Ib recommendation for the use of hemodynamic support devices in patients with CS following ST‐elevation myocardial infarction. Exchanging of hemodynamic support devices is often complicated by inability to maintain percutaneous vascular access upon device removal in the setting of anticoagulation. This report highlights one potential solution to the dilemma of maintaining vascular access following removal of an Impella® 2.5 mechanical support device to allow safe transition to a TandemHeart system in a patient with refractory CS. © 2013 Wiley Periodicals, Inc.
影响因子：
37.8
作者：
O'Gara, Patrick T.;Kushner, Frederick G.;Zhao, David X.
通讯作者：
Zhao, David X.